Obesity and metabolic syndromes are on the rise, causing poor health outcomes worldwide. These disorders can be modeled in mice using the diet-induced obesity (DIO) model. Diet-induced obese mice develop type 2 diabetes that mimics the human disease. Consuming high fat diet from the age of 6 weeks, the mice will develop progressive metabolic syndrome starting at about 12 weeks of age. The model is useful for studying the progression of type 2 diabetes as well as some late stage diabetic complications.
This webinar will introduce the concept of diet-induced obesity models, including preferred mouse strains as well as resistant strains and compare to other models of diabetes and metabolic syndrome. Learn about commonly used diets and how to generate diet-induced obese mice, including important factors in housing and husbandry. Case studies using diet-induced obesity mice to study both mechanisms of action as well as drug efficacy will be presented.
Viewers can expect to learn:
- Which mouse strains are suitable for diet-induced obesity research
- How diet-induced obese mice are made, including details of diet and phenotype monitoring
- Practical details regarding how diet-induced obese mice should be handled and housed
- How diet-induced obese mice can be used in drug discovery
- Typical phenotypic characteristics
There may be many networking opportunities at the DIO 101: Diet-induced Obesity in Mice. Find out more in the event details below.
|Conference/Event Dates:||06/23/2016 - 06/23/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Pharmaceutical, Professional Healthcare|
|Audience:||Directors & researchers from pharma and biotech companies, as well as CROs, including those working within the therapeutic areas of cardiology, metabolism and obesity.|
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.